UEG Week 2025 [0.03%]
2025年UEG周
Rob Brierley
Rob Brierley
Efficacy of behavioural therapies for irritable bowel syndrome: a systematic review and network meta-analysis [0.03%]
行为疗法治疗肠易激综合征的疗效：系统评价和网络meta分析
Elyse R Thakur,Mais Khasawneh,Paul Moayyedi et al.
Elyse R Thakur et al.
Background: Irritable bowel syndrome (IBS) management guidelines recommend that behavioural therapies, particularly brain-gut behaviour therapies, should be considered as a treatment. Some, such as IBS-specific cognitive ...
Evidence without evolution: a call for precision behavioural therapy in irritable bowel syndrome [0.03%]
无从谈起的证据：对肠易激综合征精确行为疗法的需求呼吁
Sophie R Abber,Helen Burton-Murray
Sophie R Abber
Alberto Pilotto,Carlo Custodero,Lucilla Crudele et al.
Alberto Pilotto et al.
Disorders of the gastrointestinal tract are common in those aged 65 years or older, impairing their quality of life and potentially increasing morbidity and mortality risk. Unlike many organ systems, the luminal gastrointestinal tract does ...
Peripheral blood DNA methylation signatures to predict treatment response in Crohn's disease - Authors' reply [0.03%]
对克罗恩病治疗反应的外周血DNA甲基化标志物预测的研究——作者答复
Andrew Y F Li Yim,Evgeni Levin,Wouter J de Jonge et al.
Andrew Y F Li Yim et al.
Peripheral blood DNA methylation signatures to predict treatment response in Crohn's disease [0.03%]
预测克罗恩病治疗反应的外周血DNA甲基化标志物
Hui Li,Jingni Zeng,Lu Zhang et al.
Hui Li et al.
Oliver Old,Paul Moayyedi,Janusz Jankowski et al.
Oliver Old et al.
Sadé L Assmann,Daniel Keszthelyi,Merel L Kimman et al.
Sadé L Assmann et al.
Zubing Mei,De Zheng,Qingming Wang et al.
Zubing Mei et al.
Sagnik Biswas,Shalimar
Sagnik Biswas